28 de noviembre de 2020
25 de junio de 2007
- Comunicado -

Cialis(R) (tadalafil) de una dosis diaria aprobado por la CE para tratar la disfunción eréctil

(1) Cialis(R) es una marca comercial registrada de Eli Lilly.
(2) Draft Summary of Product Characteristics, Data on file
(3) Annex II, section B, page. 37. Summary of Product Characteristics.
Data on file.
(4) Data were extrapolated from Feldman HA, Goldstein I, Hatzichristou
DG, Krane RJ. Impotence and its Medical and Psychosocial Correlates:
Results of the Massachusetts Male Aging Study, Journal of Urology.
Vol. 151, 54-61, January 1994 and World Population Projection Program
Of United Nations (2002 Revision) with indirect standardization.
(5) Shabsigh, R. (2002). Back To Great Sex: Overcome ED and Reclaim Lost
Intimacy. New York: Kensington.
(6) Diseases and Conditions: Impotence,
http://www.impotence.org/FAQ/index.asp. Data accessed 11/20/03.
(7) Lue, Tom F. Erectile Dysfunction. N Engl J Med 2000; 342: 1802-1813.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

Keri McGrath, +1-317-651-6001, o Frances Beves, +44-127-648-4810, ambos de Eli Lilly and Company. Fotografía: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ; AP Archive: http://photoarchive.ap.org ; PRN Photo Desk photodesk@prnewswire.com